Select Page

Matterhorn Biosciences

Description: Matterhorn Biosciences develops MR1-targeting cellular therapies to detect and kill cancer cells via T cell receptors, leveraging breakthrough discoveries.
Country: Switzerland
Based in: Basel
Founded: 2020
Funding Stage: Seed
Tags: ['Biopharma', 'Biotechnology', 'Life Science', 'Medical']

Categories

Details about how we process your information are available in our Privacy Policy.